• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[与COVID-19相关的死亡]

[COVID-19-associated deaths].

作者信息

Gleich S, Graw M, Viehöver S, Schmidt S, Wohlrab D

机构信息

Gessundheitsreferat, LH München, Bayerstr. 28a, 80335 München, Deutschland.

Institut für Rechtsmedizin, Ludwig-Maximilians-Universität München, München, Deutschland.

出版信息

Rechtsmedizin (Berl). 2021;31(5):408-417. doi: 10.1007/s00194-021-00455-y. Epub 2021 Feb 15.

DOI:10.1007/s00194-021-00455-y
PMID:33612978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7884065/
Abstract

INTRODUCTION

In December 2019, the new infectious coronavirus disease 2019 (COVID-19) first appeared in China. So far, no systematic evaluation of death certificates of COVID-19-associated deaths has been presented.

METHODS

The death certificates of all deaths in Munich during the period from 1 March to 31 July 2020 were analyzed. The previously defined inclusion criteria were the indication of corona, COVID-19 and SARS-CoV‑2 in the death certificates. The variables were entered anonymously according to a developed key. The collected data were evaluated descriptively.

RESULTS

In the period under investigation, a total of 5840 people died in the Munich City area. Of these deaths 332 (5.7%) were COVID-19-associated. In 281 deaths (84.6%) there was a definite COVID-19 and in 51 deaths (15.4%) the suspicion of this disease. The most frequent causes of death were acute respiratory distress syndrome or respiratory insufficiency (59.1%), multiple organ failure (21.4%) and sepsis (10%). An average of 1.8 pre-existing illnesses were reported in the death certificates. Most frequently mentioned were diseases of the circulatory system (54.8%), the nervous system (22.8%) and metabolic diseases (18.9%). The average age at death was 79 years and the most frequent place of death was a hospital (85%). An autopsy was attempted by the doctors who issued the death certificates for 18.1% of the collective, most frequently in the case of unexplained or unnatural causes of death and young age of the deceased. Clinical pathological autopsies were performed on 11% of the collective and judicial autopsies on 1%.

DISCUSSION

This study is the first evaluation of death certificates with respect to the novel infectious COVID-19. Number and essential characteristics of COVID-19-associated deaths in Munich during the so-called first wave could be mapped. The interest of physicians in autopsies was rather low despite the appearance of a new infectious disease.

摘要

引言

2019年12月,新型传染性冠状病毒病2019(COVID-19)首次在中国出现。迄今为止,尚未有对与COVID-19相关死亡的死亡证明进行系统评估的报告。

方法

对2020年3月1日至7月31日期间慕尼黑所有死亡病例的死亡证明进行分析。先前定义的纳入标准是死亡证明中出现“冠状病毒”“COVID-19”和“SARS-CoV-2”字样。变量根据制定的编码进行匿名录入。对收集到的数据进行描述性评估。

结果

在调查期间,慕尼黑市地区共有5840人死亡。其中332例(5.7%)死亡与COVID-19相关。确诊COVID-19的有281例(84.6%),疑似病例51例(15.4%)。最常见的死亡原因是急性呼吸窘迫综合征或呼吸功能不全(59.1%)、多器官功能衰竭(21.4%)和败血症(10%)。死亡证明中平均报告有1.8种既往疾病。最常提及的是循环系统疾病(54.8%)、神经系统疾病(22.8%)和代谢性疾病(18.9%)。平均死亡年龄为79岁,最常见的死亡地点是医院(85%)。开具死亡证明的医生对18.1%的死者进行了尸检尝试,最常见于死因不明或非自然死亡以及死者年龄较轻的情况。对11%的死者进行了临床病理尸检,1%进行了司法尸检。

讨论

本研究是对新型传染性COVID-19死亡证明的首次评估。可以梳理出所谓第一波疫情期间慕尼黑与COVID-19相关死亡的数量及基本特征。尽管出现了一种新的传染病,但医生对尸检的兴趣相当低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36f/7884065/579fcfa6270b/194_2021_455_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36f/7884065/d4146d133255/194_2021_455_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36f/7884065/ff781c768bed/194_2021_455_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36f/7884065/1f73db972df3/194_2021_455_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36f/7884065/579fcfa6270b/194_2021_455_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36f/7884065/d4146d133255/194_2021_455_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36f/7884065/ff781c768bed/194_2021_455_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36f/7884065/1f73db972df3/194_2021_455_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36f/7884065/579fcfa6270b/194_2021_455_Fig4_HTML.jpg

相似文献

1
[COVID-19-associated deaths].[与COVID-19相关的死亡]
Rechtsmedizin (Berl). 2021;31(5):408-417. doi: 10.1007/s00194-021-00455-y. Epub 2021 Feb 15.
2
[COVID-19- and influenza-associated deaths in Munich as of March 2020-a standardized analysis of death certificates].[截至2020年3月慕尼黑与新冠病毒病和流感相关的死亡情况——死亡证明的标准化分析]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Sep;64(9):1125-1135. doi: 10.1007/s00103-021-03392-z. Epub 2021 Aug 16.
3
[COVID-19 deaths among residents of inpatient nursing homes in Munich-causes and places of death].[慕尼黑住院养老院居民中的新冠死亡病例——死因及死亡地点]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Sep;64(9):1136-1145. doi: 10.1007/s00103-021-03395-w. Epub 2021 Aug 11.
4
[What are the effects of different places of death of old people?].[老年人在不同死亡地点会有什么影响?]
Rechtsmedizin (Berl). 2023;33(1):40-51. doi: 10.1007/s00194-022-00584-y. Epub 2022 Jul 25.
5
Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.死于 SARS-CoV-2 感染——德国汉堡首例连续 80 例尸检研究。
Int J Legal Med. 2020 Jul;134(4):1275-1284. doi: 10.1007/s00414-020-02317-w. Epub 2020 Jun 4.
6
No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science.未对新冠死亡病例进行尸检:错失的机会与科学的封锁
J Clin Med. 2020 May 14;9(5):1472. doi: 10.3390/jcm9051472.
7
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
8
The Role of COVID-19 in the Death of SARS-CoV-2-Positive Patients: A Study Based on Death Certificates.新型冠状病毒肺炎在严重急性呼吸综合征冠状病毒2阳性患者死亡中的作用:一项基于死亡证明的研究
J Clin Med. 2020 Oct 27;9(11):3459. doi: 10.3390/jcm9113459.
9
Descriptive study of causes of death and COVID-19-associated morbidities from the New York City electronic death record: first wave of the pandemic March-July 2020.描述性研究:2020 年 3 月至 7 月大流行第一波期间,纽约市电子死亡记录中的死亡原因和与 COVID-19 相关的合并症。
BMJ Open. 2024 Apr 3;14(4):e072441. doi: 10.1136/bmjopen-2023-072441.
10
[Places of death of COVID-19 patients: an observational study based on evaluated death certificates from the city of Muenster, Germany (2021)].[新冠病毒肺炎患者的死亡地点:一项基于德国明斯特市(2021年)经评估的死亡证明的观察性研究]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023 Sep;66(9):962-971. doi: 10.1007/s00103-023-03702-7. Epub 2023 May 26.

引用本文的文献

1
COVID or not COVID: attributing and reporting cause of death in a community cohort.新冠还是非新冠:社区队列中死亡原因的归因和报告。
Public Health. 2022 Apr;205:157-163. doi: 10.1016/j.puhe.2022.02.008. Epub 2022 Mar 11.

本文引用的文献

1
Clinical Outcomes in Young US Adults Hospitalized With COVID-19.美国感染新冠病毒住院的年轻成年人的临床结局
JAMA Intern Med. 2020 Sep 9;181(3):379-81. doi: 10.1001/jamainternmed.2020.5313.
2
Sex differences in immune responses that underlie COVID-19 disease outcomes.COVID-19 疾病结局相关的免疫反应中的性别差异。
Nature. 2020 Dec;588(7837):315-320. doi: 10.1038/s41586-020-2700-3. Epub 2020 Aug 26.
3
[Histopathological findings following SARS-CoV-2 infection with and without treatment-Report of three autopsies].[新型冠状病毒感染有无治疗后的组织病理学发现——三例尸检报告]
Rechtsmedizin (Berl). 2020;30(5):336-343. doi: 10.1007/s00194-020-00408-x. Epub 2020 Jul 6.
4
Evidence for systematic autopsies in COVID-19 positive deceased: Case report of the first German investigated COVID-19 death.COVID-19阳性死者进行系统尸检的证据:首例德国调查的COVID-19死亡病例报告。
Rechtsmedizin (Berl). 2020;30(3):184-189. doi: 10.1007/s00194-020-00401-4. Epub 2020 May 25.
5
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study.10021 例新冠肺炎住院患者的病例特征、资源利用和结局:一项观察性研究。
Lancet Respir Med. 2020 Sep;8(9):853-862. doi: 10.1016/S2213-2600(20)30316-7. Epub 2020 Jul 28.
6
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
7
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis.COVID-19 住院患者的急性并发症和死亡率:系统评价和荟萃分析。
Crit Care. 2020 Jul 2;24(1):389. doi: 10.1186/s13054-020-03022-1.
8
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS.50 例 COVID-19 住院患者合并与不合并 ARDS 的特征。
Dtsch Arztebl Int. 2020 Apr 17;117(16):271-278. doi: 10.3238/arztebl.2020.0271.
9
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.《纽约市 COVID-19 重症成人的流行病学、临床病程和结局:一项前瞻性队列研究》
Lancet. 2020 Jun 6;395(10239):1763-1770. doi: 10.1016/S0140-6736(20)31189-2. Epub 2020 May 19.
10
Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York.在纽约布朗克斯的 COVID-19 患者队列中,严重肥胖、年龄增长和男性性别与住院期间的不良结局独立相关,并与更高的住院死亡率相关。
Metabolism. 2020 Jul;108:154262. doi: 10.1016/j.metabol.2020.154262. Epub 2020 May 16.